M
LIVE

Serial Number

50072917

Owner

Mentari Therapeutics, Inc.

Attorney

Austin D. Padgett, Esq.

Filing Date

Aug 26, 2026

Add to watchlist:

No watchlists yet
View on USPTO

M Trademark

Serial Number: 50072917

M is a trademark filed by Mentari Therapeutics, Inc. on August 26, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Mentari Therapeutics, Inc. (13 trademarks)

221 Crescent Street, Building 23, Suite 105
Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

August 26, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the prevention and treatment of migraine, chronic migraine, episodic migraine, and migraine-associated disorders; biologics for the prevention and treatment of migraine; biopharmaceutical preparations for the prevention and treatment of migraine and migraine-associated disorders; biological preparations for therapeutic use in the prevention and treatment of migraine; bispecific antibodies for therapeutic use, namely for the prevention of migraine; pharmaceutical preparations comprising anti-PACAP antibodies for the prevention and treatment of migraine; pharmaceutical preparations comprising anti-CGRP antibodies for the prevention and treatment of migraine; pharmaceutical preparations comprising bispecific antibodies targeting both CGRP and PACAP for therapeutic use in the prevention of migraine; pharmaceutical preparations for the treatment of neurological disorders; biologic preparations for the treatment of neurological disorders; pharmaceutical preparations for subcutaneous injection for the prevention of migraine; injectable pharmaceutical preparations in the field of migraine prevention; pharmaceutical preparations for self-administration via autoinjector for the prevention of migraine; pharmaceutical preparations for quarterly subcutaneous administration for the prevention of migraine; monospecific antibodies for therapeutic use, namely for the prevention of migraine

Filing History

APPLICATION FILING RECEIPT MAILED
Aug 26, 2026 MAFR
NEW APPLICATION ENTERED
Aug 26, 2026 NWAP